SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq:KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that it will be presenting a poster at the 2023 European Association for Neuro-Oncology (EANO) Annual Meeting, taking place in Rotterdam, September 21-24, 2023. The presentation will include data from its lead program, VAL-083, for the treatment of recurrent glioblastoma.
Read more at prnewswire.comKintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual Meeting
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here